Palatin Technologies (PTN) Asset Utilization Ratio (2011 - 2026)
Palatin Technologies' (PTN) quarterly Asset Utilization Ratio came in at 0.83 in Q1 2026, up 848.58% YoY from 0.09 in Q1 2025, and up 22.54% on a QoQ basis from 0.67 in Q4 2025.
Palatin Technologies (PTN) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 13 years of Asset Utilization Ratio data on file, last reported at 0.83 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 848.58% year-over-year to 0.83 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.83 (up 848.58% YoY) and the FY2024 annual result came in at 0.31, up 74.31% from the prior year.
- Asset Utilization Ratio grew to 0.83 in Q1 2026, from 0.67 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.49 in Q3 2025 to a low of 0.01 in Q1 2022.
- A 5-year average of 0.37 and a median of 0.28 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 1522.47% — and 2024, when it plunged 84.16%.
- Tracing PTN's Asset Utilization Ratio over 5 years: stood at 0.09 in 2022, then jumped by 547.72% to 0.57 in 2023, then sank by 84.16% to 0.09 in 2024, then soared by 643.94% to 0.67 in 2025, then gained by 22.54% to 0.83 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.83 (Q1 2026), 0.67 (Q4 2025), and 1.49 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Palatin Technologies | 40.86 Mn | 40.86 Mn | - | 0.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.83 |
| Dec 31, 2025 | 0.67 |
| Sep 30, 2025 | 1.49 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.57 |
| Sep 30, 2023 | 0.42 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.03 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.01 |